Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Functionally characterizing the role of two novel long non-coding RNAs on phosphodiesterase 3A function, in Mendelian hypertension.

EF 2021-22

Résumé
The number of deaths in the last 30 years due to cardiovascular diseases have been steadily rising. The major factor contributing to this is hypertension – commonly known as high blood pressure, which currently affects about 1.13 billion people globally. Plenty of high blood pressure cases have hereditary causes, however, many of the genetic components involved in causing blood pressure are still unknown. This is especially true in rare cases, such as in the syndrome known as 'hypertension with brachydactyly type E'. Individuals with this syndrome inherit severely high blood pressure and shortened fingers at once, due to mutations in a gene known as PDE3A. Large scale studies that scan the genomes of many people to associate genetic differences with specific diseases have identified genetic variations that are associated with cardiovascular diseases around the genomic region of PDE3A. This genomic region contains two genes that are classified as long non-coding RNAs. Long non-coding RNAs are genes that do not produce a protein and have been found to be key players in cellular processes and human diseases by controlling other genes. So, perhaps the two long non-coding RNAs control the way PDE3A behaves, and thus may be involved in controlling blood pressure. This study aims to elucidate the function of the two long non-coding RNAs. First, I will use various web-based tools and publicly available datasets to predict the functionality of the long non-coding RNAs. Next, I will use gene editing tools to alter the two long non-coding RNAs and observe how it will affect the way PDE3A behaves. Overall, this study can provide insight into two new genetic components that may be involved in controlling blood pressure and can be potential targets for developing treatments.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
480738
Name
Attia Mariam
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functionally characterizing the role of two novel long non-coding RNAs on phosphodiesterase 3A function, in Mendelian hypertension.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood Pressure Therapies; Cardiovascular Diseases; Crispr-Cas9; Gene Expression; Gene Regulatory Mechanisms; Genetic Diseases; Genetic Variants; Genomics; Hypertension; Long Non-Coding Rnas
Abstract
The number of deaths in the last 30 years due to cardiovascular diseases have been steadily rising. The major factor contributing to this is hypertension – commonly known as high blood pressure, which currently affects about 1.13 billion people globally. Plenty of high blood pressure cases have hereditary causes, however, many of the genetic components involved in causing blood pressure are still unknown. This is especially true in rare cases, such as in the syndrome known as 'hypertension with brachydactyly type E'. Individuals with this syndrome inherit severely high blood pressure and shortened fingers at once, due to mutations in a gene known as PDE3A. Large scale studies that scan the genomes of many people to associate genetic differences with specific diseases have identified genetic variations that are associated with cardiovascular diseases around the genomic region of PDE3A. This genomic region contains two genes that are classified as long non-coding RNAs. Long non-coding RNAs are genes that do not produce a protein and have been found to be key players in cellular processes and human diseases by controlling other genes. So, perhaps the two long non-coding RNAs control the way PDE3A behaves, and thus may be involved in controlling blood pressure. This study aims to elucidate the function of the two long non-coding RNAs. First, I will use various web-based tools and publicly available datasets to predict the functionality of the long non-coding RNAs. Next, I will use gene editing tools to alter the two long non-coding RNAs and observe how it will affect the way PDE3A behaves. Overall, this study can provide insight into two new genetic components that may be involved in controlling blood pressure and can be potential targets for developing treatments.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Attia, Mariam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~